Details for 2018851555

Up to date per 02.04.2026

Actions

Title / Product Name

EXON-18- UND/ODER EXON-21-MUTANTER EGFR-SELEKTIVER INHIBITOR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018851555

EP Publication Number

3677266

E-Number

1650118

Language

PCT Number

JP18032314

Publication Date

08.07.2020 A

17.01.2024 B1

Registration Date

17.01.2024

AT Publication Date

15.02.2024

Application Date

31.08.2018

Registration Number

Priorities

01.09.2017

2017168606

IPC

A61K 31/519 20060101AFI20210408BHEP

Maximum Duration of Protection

31.08.2038

Owner

Taiho Pharmaceutical Co., Ltd.1-27, Kandanishiki-cho Chiyoda-ku, Tokyo 101-8444JP

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

ABE, Naomic/o TAIHO PHARMACEUTICAL CO. LTD. 3 Okubo Tsukuba-shi Ibaraki 300-2611JP

HASAKO, Shinichic/o TAIHO PHARMACEUTICAL CO. LTD. 3 Okubo Tsukuba-shi Ibaraki 300-2611JP

Information about Fees